Preliminary evaluation of psychometric properties of the Finnish Borderline Personality Disorder Severity Index: Oulu-BPD-Study

Nordic Journal of Psychiatry

Volumn 67, Issue 5, 2013, Pages 312-319

  Leppänen, Virpi ^a,b   Lindeman, Sari ^a,c,d   Arntz, Arnoud ^e   Hakko, Helinä ^f  

^a UNIVERSITY OF OULU   (Finland)

^b Oulu Equine Hospital   (Finland)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

^d Central Finland Health Care District   (Finland)

^e MAASTRICHT UNIVERSITY   (Netherlands)

^f OULU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Mental healthcare services; Psychometrics; Reliability; Validity

Indexed keywords

ADULT; ARTICLE; BORDERLINE PERSONALITY DISORDER SEVERITY INDEX IV; BORDERLINE STATE; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; FEEDBACK SYSTEM; FEMALE; FOLLOW UP; HUMAN; INTERVIEW; MALE; MENTAL HEALTH CARE; PSYCHOMETRY; RANDOMIZED CONTROLLED TRIAL; STRUCTURED CLINICAL INTERVIEW FOR DSM DISORDERS;

ADULT; BORDERLINE PERSONALITY DISORDER; FEMALE; FINLAND; HUMANS; MALE; MIDDLE AGED; PSYCHOMETRICS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84884527138     PISSN: 08039488     EISSN: 15024725     Source Type: Journal    
DOI: 10.3109/08039488.2012.745600     Document Type: Article

References (20)

1. Weertman A, Arntz A, Dreessen L, van Velzen C, Vertommen, S. Short-interval test retest interrater reliability of the Dutch version of the Structured Clinical Interview for DSM-IV personality disorders (SCID-II). J Pers Dis 2003; 7: 562-7.
2. Zimmerman, M. Diagnosing personality disorders. A review of issues and research methods. Arch Gen Psychiatry 1994; 51: 225-45.
3. Zanarini MC, Stanley B, Black DW, Markowitz JC, Goodman M, Pilkonis P. et al. Methodological considerations treatment trials for persons personality disorder. Ann Clin Psychiatry 2010; 22: 75-83.
4. Zanarini MC, Vujanovic AA, Parachini EA, Boulanger JL, Frankenburg FR, Hennen J. http://www.ncbi.nlm.nih.gov/pubmed?term -; Zanarini Rating Scale for Borderline Personality Disorder (ZAN-BPD): A continuous measure of Rating Scale for Borderline Personality Disorder DSM-IV borderline psychopathology. J Pers Disord 2003;17:233-42.
5. Pfohl B, Blum N, St John D, McCormick B, Allen, J, Black DWhttp://www.ncbi.nlm.nih.gov/pubmed?term Reliability and validity of the Borderline Evaluation of Severity Over Time (BEST): A self-rated scale to measure severity. and change in persons with borderline personality disorder. J Pers Disord 2009; 23: 281-93.
6. Bohus M, Limberger MF, Frank U, Chapman AL, Kühler T, Stieglitz R. Psychometric Properties of the Borderline Symptom List (BSL). Psychopathology, 2007; 40: 126-32.
7. Bohus M, Kleindienst N, Limberger MF, Stieglitz R, Domsalla M, Chapman AL et al. The Short Version of the Borderline Symptom List (BSL-23): Development and initial data on psychometric properties. Psychopathology 2009; 42: 32-9.
8. Arntz A, van den Hoorn M, Cornelis J, Verheul, R, van den Bosch W, die Bie, A. (2003). Reliability and validity of the Borderline Personality Disorder Severity Index. J Pers Dis 2003; 17: 45-59.
9. Bellino, S, Paradiso E, Bogetto F. Efficacy and tolerability of quetiapine in the treatment of borderline personality disorder: A pilot study. J Clin Psychiatry 2006; 67: 1042-6.
10. Bellino S, Paradiso E, Bogetto F. Oxcarbazepine in the treatment of borderline personality disorder: A pilot study. J Clin Psychiatry 2005; 66: 1111-5.
11. Giesen-Bloo J, van Dyck R, Spinhoven P, van Tilburg W, Dirksen C, van Asselt T. et al. Outpatient psychotherapy for borderline personality disorder: Randomized trial of schema-focused therapy vs transference-focused psychotherapy. Arch Gen Psychiatry 2006; 63: 649-58.
12. Nadort M, Arntz A, Smit JH, Giesen-Bloo J, Eikelenboom, M, Spinhoven P. et al. Implementation of outpatient schema therapy for borderline personality disorder with versus without crisis support by the therapist outside office hours: A randomized trial. Behav Res Ther 2009; 47: 961-73.
13. Rinne T, de Kloet ER, Wouters L, Goekoop JG, de Rijk RH, van den Brink W. Fluvoxamine reduces responsiveness of HPA axis in adult female BPD patients with a history of sustained childhood abuse. Neuropsychopharmacology 2003; 28: 126-32.
14. Rinne T, van den Brink W, Wouters L, van Dyck R. SSRI treatment of borderline personality disorder: A randomized, placebo-controlled clinical trial for female patients with borderline personality disorder. Am J Psychiatry 2002; 159: 2048-54.
15. Verheul R, van den Bosch LM, Koeter MW, de Ridder MA, Stijnen, T, van den Brink W. Dialectical behaviour therapy for women with borderline personality disorder: 12-month randomised clinical trial in The Netherlands. Br J Psychiatry 2003; 182: 135-40.
16. Giesen-Bloo J H, Wachters LM, Schouten E, Arntz, A. The Borderline Personality Disorder Severity Index-IV: Psychometric evaluation and dimensional structure. Pers Individ Dif 2010; 49: 136-41.
17. Spizer RL, Williams JBW, Gibbon M, First MB. Structured Clinical Interview for DSM-III-R Personality Disorders (SCID-II, 9/1/89 Version). New York, NY: Biometrics Research Departmen t; 1989.
18. Young JE, Klosko JS, Weishaar ME. Schema therapy. A practitioner' s guide. New York: The Guilford Press; 2003. p. 41.
19. Hair J F Jr, Andersson RE, Tatham RL, Black WC. Multivariate data analyses, 6th ed. Upper Saddle River, NJ: Pearson Prentice Hall; 1998. p. 118.
20. Nunnally J, Bernstein I. Psychometric theory, 3rd edition. New York: McGraw Hill; 1994. p. 248-92.